To what extent can our intestinal microbiota predict the risk of developing diseases? In the case of multifactorial diseases, bacterial taxa alone do not provide much information, according to a study ...

A combination of silybin and carvedilol for treating liver fibrosis is more effective than either drug alone. | Drug ...

TechBio company MultiOmic Health (MOH) initially set out to build an artificial intelligence (AI)-enabled platform to research metabolic dysfunction-associated conditions. In just three years, not ...

A research team provides an overview of how engineered probiotics—genetically modified beneficial microbes—are being transformed into living medicines capable of sensing disease, delivering therapies, ...

Obesity is one of the most serious and ubiquitous health problems worldwide. Obesity can be defined as a multifactorial ...

Interview has been edited for readability. AJMC®: What percentage of your practice is dedicated to treating dry eye disease (DED), and has this changed over time? Devries: Approximately 90% of my ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...